Abstract:The objective of this study was to evaluate the gum from Hakea gibbosa (hakea) as a sustained-release and mucoadhesive component in buccal tablets for a model peptide, namely, salmon calcitonin. Flat-faced core tablets containing either 12 or 32 mg of hakea and 40 microg (200 IU) of salmon calcitonin (sCT) per tablet were formulated using a direct compression technique and were coated with Cutina on all but one face. The in vitro release profiles were sigmoidal in nature and according to a mathematical model indicated super Case II transport as the primary mechanism of release. The resulting plasma sCT and calcium concentrations were determined following both intravenous administration and buccal application of mucoadhesive tablets in rabbits. Following intravenous administration, the mean values determined for t(1/2) (alpha), t(1/2) (beta), V(d), and CL for sCT were 0.76 +/- 0.06 min, 67 +/- 18 min, 1484 +/- 454 mL/kg, and 19 +/- 2 mL/min.kg, respectively. Following the application of the mucoadhesive buccal tablets which contained 40 microg of sCT and either 12 or 32 mg of hakea, the calculated apparent bioavailability (F) and clearance (CL) were 37 +/- 6% and 19 +/- 3.3 mL/min.kg and 16 +/- 8% and 18 +/- 0.4 mL/min. kg, respectively. Serum calcium concentrations indicated that biologically active sCT was delivered across the rabbit buccal mucosa. The strength of mucoadhesion of the tablets was also quantitated in terms of the force of detachment as a function of time. The force of detachment for the mucoadhesive buccal tablets containing either 12 or 32 mg of hakea and 40 microg of sCT increased from 4.47 +/- 0.68 to 8.41 +/- 1.0 N and 8.23 +/- 1.62 to 14.98 +/- 1.63 N, respectively, from 5 to 90 min following application to excised rabbit intestinal mucosa. These results demonstrate that the novel, natural gum from Hakea gibbosa may be used to sustain the release of sCT from a unidirectional-release buccal tablet. The mechanism of in vitro release is likely to involve peptide diffusion/polymer dissolution. The mucoadhesive strength, as measured by the force of detachment, can be modulated by altering the amount of hakea in the tablet. The mucoadhesive buccal tablets described in this paper represent an improved transbuccal delivery system for therapeutic polypeptides.

Approach and strategy of perioperative agent administration for patients on chronic anticoagulation therapy

The Application of Triple Antithrombotic Therapy Combined with Aspirin,Clopidogrel and Warfarin in Patients with Coronary Heart Disease

Strategies for Perioperative Anticoagulant Reversal in Orthopedic Surgery: A Review

Several critical issues of prevention and management for the perioperative venous thrombosis

Experts' Consensus on Perioperative Management of Tooth Extractions in Patients Receiving Oral Antithrombotic Treatment

Management of the risk of bleeding and thrombosis in perioperative patients with liver cirrhosis

Medical Clinics of North America-Periprocedural Antithrombotics: Prophylaxis and Interruption

First- and second-order conditioning in goldfish and their relation to the telencephalon.

Controversy and consensus on the diagnosis and treat-ment of Perioperative venous thromboembolism diseases

[The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis].

Perioperative antithrombotic strategy in coronary intervention therapy for the patients with coronary heart disease treated with long-term warfarin anticoagulation

The Management and Antithrombotic Strategies of Patients with Coronary Artery Disease and High Bleeding Risk

Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets.

Perioperative Drug Treatment Decisions for Surgical Patients

[Current Status and Prospect of Perioperative Thrombus Management in Gastrointestinal Cancer].

[Perioperative management of patients on NOACs]

Analysis of Radiative Effect under Local Thermal Non-Equilibrium Conditions in Porous Media-Application to a Solar Air Receiver

An essential role of KREPB4 in RNA editing and structural integrity of the editosome in Trypanosoma brucei.

Management of perioperative anticoagulation in patients with mechanical heart valve replacement undergoing laparoscopic cholecystectomy: a case report of postoperative cerebral embolism

Perioperative antithrombotic medication: An approach for the primary care clinician

Anticoagulant therapy in orthopedic surgery – a review on anticoagulant agents, risk factors, monitoring, and current challenges